Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Browsing Tag

Pfizer

22 posts
NNovartis
Novartis and Novo Nordisk heart drugs fail despite genetic proof, STAT's Herper says biology "doesn't make sense" — BigGo Finance
Read More

Novartis and Novo Nordisk heart drugs fail despite genetic proof, STAT’s Herper says biology “doesn’t make sense” — BigGo Finance

  • 2026-11-13
Two of the most genetically bulletproof cardiovascular drugs ever put into patients just failed — and they did…
RRoche
Roche Freezes All German Investment in Pushback Against Drug Rebate Hike to 15.5% — BigGo Finance
Read More

Roche Freezes All German Investment in Pushback Against Drug Rebate Hike to 15.5% — BigGo Finance

  • 2026-10-21
Swiss pharmaceutical giant Roche has fully frozen all future investment decisions in Germany over the country’s healthcare cost-cutting…
RRoche
Fierce Biotech Editors: The Next Vertex Is Taking On Targets Big Pharma Abandoned — BigGo Finance
Read More

Fierce Biotech Editors: The Next Vertex Is Taking On Targets Big Pharma Abandoned — BigGo Finance

  • 2026-10-09
The most telling signal from this year’s Fierce 15 list isn’t which companies made it — it’s what…
NNovartis
The Zacks Analyst Blog Highlights Pfizer, Novartis, Candel and Janux
Read More

The Zacks Analyst Blog Highlights Pfizer, Novartis, Candel and Janux

  • 2026-09-16
For Immediate Release Chicago, IL – September 16 2026 – Zacks.com announces the list of stocks and ETFs…
NNovartis
Novartis India Acquires Pfizer's Minipress Brand for ₹1250 Crore Amidst Pharma Challenges, ETPharma
Read More

Novartis India Acquires Pfizer’s Minipress Brand for ₹1250 Crore Amidst Pharma Challenges, ETPharma

  • 2026-09-09
Mumbai: ChrysCapital-backed Novartis India has agreed to acquire Pfizer’s Minipress trademark, a high blood pressure therapy, for a…
NNovartis
Novartis India acquires Pfizer brands for $132m
Read More

Novartis India acquires Pfizer brands for $132m

  • 2026-09-08
Novartis India has agreed to pay Rs12.5bn ($132m) to acquire the Minipres and Minipress trademarks in India, along…
NNovartis
Newsletter
Read More

ChrysCap-controlled Novartis India to buy Pfizer’s blood pressure brand Minipress

  • 2026-09-08
Credit: Pixabay Novartis India Ltd, controlled by homegrown private equity firm ChrysCapital, has inked a deal to acquire…
NNovartis
360 One Group CEO Bhagat buys 1.3 lakh shares of Novartis India for Rs 22 cr
Read More

360 One Group CEO Bhagat buys 1.3 lakh shares of Novartis India for Rs 22 cr

  • 2026-09-07
Karan Bhagat, founder and CEO of 360 One Group, on Monday bought 1.3 lakh shares of Novartis India…
NNovartis
Business Standard
Read More

Novartis India buys Minipress brands from Pfizer for ₹1,250 crore | Company News

  • 2026-09-07
Novartis India has acquired the Minipress and Minipres trademarks in India and certain related intellectual property rights from…
NNovartis
Novartis India Acquires Pfizer
Read More

Novartis India Acquires Pfizer’s Minipress for ₹1,250 Cr: Rediff Moneynews

  • 2026-09-07
Novartis India buys ‘Minipress’ and ‘Minipres’ trademarks from Pfizer for ₹1,250 crore. The drug treats hypertension and BPH,…
NNovartis
Impact Shorts
Read More

Novartis India to acquire Minipress, Pfizer’s high blood pressure drug, for ₹1,250 crore

  • 2026-09-07
Novartis India said on Monday, September 7, that its board has approved the acquisition of the trademarks ‘Minipress’…
RRoche
Roche, ViiV and Horizon most reputable pharmas: patient groups
Read More

Roche, ViiV and Horizon most reputable pharmas: patient groups

  • 2026-08-20
PatientView’s annual pharma reputation report, as scored by global patient groups, ranked Roche, ViiV Healthcare and Horizon Therapeutics as the…
Switzerland
www.europesays.com